These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23580251)

  • 41. The impact of the OECD on the development of national/international risk/safety assessment frameworks.
    Gaugitsch H
    Environ Biosafety Res; 2006; 5(4):219-22. PubMed ID: 17640512
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Innovative farmers and regulatory gatekeepers: Genetically modified crops regulation and adoption in developing countries.
    Sinebo W; Maredia K
    GM Crops Food; 2016 Jan; 7(1):1-11. PubMed ID: 26954893
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Temporal allocation of metabolic tolerance to transgenic Bt cotton in beet armyworm, Spodoptera exigua (Hübner).
    Guo J; Wu G; Wan F
    Sci China Life Sci; 2011 Feb; 54(2):152-8. PubMed ID: 21318485
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Databases on biotechnology and biosafety of GMOs.
    Degrassi G; Alexandrova N; Ripandelli D
    Environ Biosafety Res; 2003; 2(3):145-60. PubMed ID: 15612413
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The structuring of GMO release and evaluation in EU law.
    von Kries C; Winter G
    Biotechnol J; 2012 Apr; 7(4):569-81. PubMed ID: 22121045
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Public Submissions on the Uganda National Biotechnology and Biosafety Bill, 2012 Reveal Potential Way Forward for Uganda Legislators to Pass the Bill.
    Masiga CW
    Front Bioeng Biotechnol; 2015; 3():152. PubMed ID: 26501057
    [TBL] [Abstract][Full Text] [Related]  

  • 47. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Information system for monitoring environmental impacts of genetically modified organisms.
    Reuter H; Middelhoff U; Graef F; Verhoeven R; Batz T; Weis M; Schmidt G; Schröder W; Breckling B
    Environ Sci Pollut Res Int; 2010 Sep; 17(8):1479-90. PubMed ID: 20414731
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Progress on biosafety assessment of marker genes in genetically modified foods].
    Yang L; Yang X
    Wei Sheng Yan Jiu; 2003 May; 32(3):239-45. PubMed ID: 12914289
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Research and regulation on biosafety of GMOs in China.
    Jia S; Peng Y
    Environ Biosafety Res; 2003; 2(1):57-9. PubMed ID: 15615070
    [No Abstract]   [Full Text] [Related]  

  • 52. [Biotechnology and relevant aspects of the New Biosafety law].
    Naves BT; Freire de Sá Mde F
    Rev Derecho Genoma Hum; 2005; (22):85-102. PubMed ID: 16385792
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of genetically modified organisms on aquatic environments: Review of available data for the risk assessment.
    Pott A; Otto M; Schulz R
    Sci Total Environ; 2018 Sep; 635():687-698. PubMed ID: 29680759
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetically engineered vegetables expressing proteins from Bacillus thuringiensis for insect resistance: successes, disappointments, challenges and ways to move forward.
    Shelton AM
    GM Crops Food; 2012; 3(3):175-83. PubMed ID: 22538234
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Awareness of GMOs in terms of the Iran biosafety act: A case study of Tehran city.
    Shooshtari A; Hajatpour Z; Ghaffari MR; Seraji F; Loni F
    Heliyon; 2024 Feb; 10(3):e25487. PubMed ID: 38352779
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preliminary assessment of framework conditions for release of genetically modified mosquitoes in Burkina Faso.
    De Freece C; Paré Toé L; Esposito F; Diabaté A; Favia G
    Int Health; 2014 Sep; 6(3):263-5. PubMed ID: 24981444
    [TBL] [Abstract][Full Text] [Related]  

  • 57. FROM Qutn TO Bt COTTON: DEVELOPMENT, ADOPTION AND PROSPECTS. A REVIEW.
    Maik W; Abid MA; Cheema HM; Khan AA; Iqbal MZ; Qayyum A; Hanif M; Bibi N; Yuan SN; Yasmeen A; Mahmood A; Ashraf J
    Tsitol Genet; 2015; 49(6):73-85. PubMed ID: 26841496
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heliothis virescens and Bt cotton in the United States.
    Blanco CA
    GM Crops Food; 2012; 3(3):201-12. PubMed ID: 22892654
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Five years of Bt cotton in China - the benefits continue.
    Pray CE; Huang J; Hu R; Rozelle S
    Plant J; 2002 Aug; 31(4):423-30. PubMed ID: 12182701
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetically modified cotton and farmers' health in China.
    Hossain F; Pray CE; Lu Y; Huang J; Fan C; Hu R
    Int J Occup Environ Health; 2004; 10(3):296-303. PubMed ID: 15473084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.